Plecanatide

Molecular formula:C65H104N18O26S4

Molecular weight: 1681.89

Patent period: —

Dositive specifications:3 mg BASE/VIAL

Injection :3 mg /once day

Oral tablets: —

Injection: —

Category:

Plecanatide Peptide Raw Material – Research-Grade Supply

Introduction

Plecanatide peptide raw material is a chemically defined synthetic peptide supplied for laboratory research, analytical reference, and pharmaceutical development activities.
Researchers and development teams use this peptide raw material when they require precise composition control, stable quality attributes, and reproducible experimental results.

Importantly, this material does not represent a finished dosage form. Instead, laboratories use it strictly as a research input under controlled experimental conditions.


Overview of the Peptide Raw Material

Plecanatide is a synthetic peptide structurally related to endogenous uroguanylin.
When manufacturers supply it as a peptide raw material, it supports research programs that demand flexibility in formulation design, concentration adjustment, and analytical evaluation.

Therefore, many biotechnology and pharmaceutical development teams prefer peptide raw materials over finished products during early-stage and comparative studies.


Key Material Characteristics

This peptide raw material offers several properties that support research and industrial workflows:

  • Defined peptide sequence produced through controlled synthesis

  • Lyophilized powder format suitable for laboratory handling

  • Research-grade quality aligned with development standards

  • Consistent batch specifications to support repeatability

  • Compatibility with analytical and formulation studies

As a result, laboratories can integrate this material smoothly into peptide-related research pipelines.


Manufacturing and Quality Standards

Manufacturers produce this peptide raw material using controlled synthesis and purification processes.
During production, teams actively monitor critical quality parameters to ensure consistent output.

Typical quality control measures include:

  • Peptide identity verification

  • Purity assessment through chromatographic analysis

  • Molecular weight confirmation

  • Impurity and residual solvent evaluation

Because of these controls, development teams can rely on stable quality across research batches.


Research and Development Applications

Laboratories use this peptide raw material in a variety of non-clinical research contexts.
For example, researchers apply it in:

  • Peptide chemistry and structural analysis

  • Analytical method development

  • Formulation and stability evaluation

  • Pharmaceutical development reference studies

  • Comparative peptide research models

However, these uses remain limited to research and industrial purposes and do not imply clinical application.


Handling and Storage Considerations

Proper handling plays a key role in maintaining peptide integrity.
Therefore, laboratories typically follow standard peptide handling protocols.

Common practices include:

  • Storing the material under controlled temperature conditions

  • Limiting exposure to moisture and light

  • Performing reconstitution and dilution in laboratory environments

  • Using the material within validated stability timeframes

By following these practices, researchers can preserve consistency throughout their studies.


Intended Use and Compliance

This peptide raw material is supplied exclusively for research and development use.

  • Not approved as a drug substance

  • Not intended for human or animal consumption

  • Not distributed as a finished pharmaceutical product

Accordingly, buyers must ensure that their use complies with applicable regulatory requirements in their jurisdiction.


Summary

Plecanatide peptide raw material supports laboratory research, analytical reference work, and pharmaceutical development studies.
Through defined chemical properties, controlled manufacturing standards, and flexible research applications, this material provides a reliable foundation for peptide-focused development programs.